Hospital News and Research

RSS

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

Acute dendritic leukaemia is a rare type of leukaemia, but one with the worst prognosis-the average patient survival rate is just 12-14 months-that is difficult to treat. Juan Cruz Cigudosa's team, from the Spanish National Cancer Research Centre's Molecular Cytogenetics Group, has for the first time sequenced the exome -the coding, or protein-generating, regions of the genome- of dendritic cell leukaemia.

24 Oct 2013

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Researchers at Karolinska Institutet in Sweden, and colleagues at University Children's Hospital Z-rich in Switzerland have managed to improve cytostatic therapy for children with the chronic immune deficiency disorder granulomatous disease prior to stem cell transplantation.

24 Oct 2013

BCG asthma effects are lost in adolescence

Any beneficial effects of the neonatal Bacillus Calmette–Guérin vaccine on childhood asthma symptoms and outcomes are likely to be transient, disappearing by adolescence, show follow-up findings from the Manchester Community Asthma Study.

23 Oct 2013

Newly discovered proteins in spinal fluid can serve as markers for Alzheimer's disease

23 Oct 2013

Doctors-in-training must employ etiquette-based communications to improve medical recovery, patient satisfaction

Johns Hopkins investigators have found that doctors-in-training are unlikely to introduce themselves fully to hospitalized patients or sit down to talk to them eye-to-eye, despite research suggesting that courteous bedside manners improve medical recovery along with patient satisfaction.

23 Oct 2013

Accelera Innovations, Lambert Private Equity sign Investment Agreement to support growth initiatives

Accelera Innovations, Inc. a Chicago-based healthcare software-as-a-service provider (the "Company") today announced it has entered into a Standby Equity Purchase Agreement ("Investment Agreement") with Lambert Private Equity, LLC, (the "Investor").

23 Oct 2013

A simple blood test may reveal the earliest signs of pancreatic cancer

Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always fatal because it isn't usually discovered until it has spread to other parts of the body.

23 Oct 2013

Startup Wins Five-Year Exclusive License To Decode Genetics Platform

...

23 Oct 2013

Study identifies new genes involved in autism

A scientific study published on the journal Molecular Psychiatry identifies new genes involved in autism, a polygenic disorder that is difficult to diagnose and treat. Autism spectrum disorders represent a group of neurodevelopmental disorders which affect one out of 80-100 children.

23 Oct 2013

The Melting Pot, St. Jude Children's Research Hospital partner to raise funds for cancer research

The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.

23 Oct 2013

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

In a move to address a significant unmet need in hepatitis C in Canada, the University Health Network, together with Boehringer Ingelheim (Canada) Ltd., announced today a multi-year partnership that aims to improve care, education and support for patients with hepatitis C. The program, known as Link-C, aims to improve access to hepatitis C care and treatment in remote areas of Ontario and other parts of Canada.

23 Oct 2013

Tissue-engineered transplants safe and effective in the long term: Study

New results published in The Lancet today [Wednesday 23 October] reveal that five years after the first successful transplantation of a tissue-engineered airway (reported in The Lancet in 2008) the recipient continues to enjoy a good quality of life, and has not experienced any immunological complications or rejection of the implanted airway.

23 Oct 2013

eXtasy software suite quickly and accurately traces origins of genetic disorders

In a bioinformatics breakthrough, iMinds - STADIUS - KU Leuven researchers have successfully applied advanced artificial intelligence to enable the automated analysis of huge amounts of genetic data.

23 Oct 2013

Study reveals that glial cells are integral to brain function

New research by scientists at UC San Francisco shows that one of the brain's fundamental self-protection mechanisms depends on coordinated, finely calibrated teamwork among neurons and non-neural cells knows as glial cells, which until fairly recently were thought to be mere support cells for neurons.

23 Oct 2013

Scientists reveal first comprehensive genomic analysis of aggressive lymphomas

Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.

23 Oct 2013

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more. GO is an antibody-drug conjugate comprised of an anti-CD33 monoclonal antibody linked to a cytotoxic agent.

23 Oct 2013

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.

23 Oct 2013

Homeless people are extremely frequent users of health services, finds research

Single women who are homeless visit a hospital Emergency Department an average of more than twice a year, 13 times more often than women in the general population, new research has found.

23 Oct 2013

Leapfrog honors Holy Name Medical Center with "A" grade

Holy Name Medical Center was honored with an "A" grade from The Leapfrog Group, in its Fall 2013 update to the Hospital Safety Score, which rates how well hospitals protect patients from accidents, errors, injuries and infections.

23 Oct 2013

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

23 Oct 2013

Hospital News and Research

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

BCG asthma effects are lost in adolescence

Newly discovered proteins in spinal fluid can serve as markers for Alzheimer's disease

Doctors-in-training must employ etiquette-based communications to improve medical recovery, patient satisfaction

Accelera Innovations, Lambert Private Equity sign Investment Agreement to support growth initiatives

A simple blood test may reveal the earliest signs of pancreatic cancer

Startup Wins Five-Year Exclusive License To Decode Genetics Platform

Study identifies new genes involved in autism

The Melting Pot, St. Jude Children's Research Hospital partner to raise funds for cancer research

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

Tissue-engineered transplants safe and effective in the long term: Study

eXtasy software suite quickly and accurately traces origins of genetic disorders

Study reveals that glial cells are integral to brain function

Scientists reveal first comprehensive genomic analysis of aggressive lymphomas

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

Homeless people are extremely frequent users of health services, finds research

Leapfrog honors Holy Name Medical Center with "A" grade

Medical errors: The third cause of death in the US

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News